Pharmaxis is an Australian drug development company formed in Sydney, Australia. The company has developed an expertise in developing drugs for inflammatory and fibrotic diseases, and a focus on myelofibrosis. The company was formed in 1998 and became public on the Australian Stock Exchange in 2003, to this date on 21st April 2022, the company’s … Continue reading Pharmaxis